ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sialylated Human Milk Oligosaccharides (HMO) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7I16886
Home | Market Reports | Food & Drink
Global Sialylated Human Milk Oligosaccharides HMO Market Research Report 2024
BUY CHAPTERS

Global Sialylated Human Milk Oligosaccharides (HMO) Market Research Report 2025

Code: QYRE-Auto-7I16886
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem
FrieslandCampina Ingredients

Sialylated Human Milk Oligosaccharides (HMO) Market Size

The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 467.7 million in 2023 and is forecast to a readjusted size of US$ 1227.5 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.

Sialylated Human Milk Oligosaccharides (HMO) Market

Sialylated Human Milk Oligosaccharides (HMO) Market

The global market for Sialylated Human Milk Oligosaccharides (HMO) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3’-Sialyllactose (3’-SL) and 6′-sialyllactose (6’-SL) are two simplest sialylated HMOs.
North American market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sialylated Human Milk Oligosaccharides (HMO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sialylated Human Milk Oligosaccharides (HMO) include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc., FrieslandCampina Ingredients, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sialylated Human Milk Oligosaccharides (HMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sialylated Human Milk Oligosaccharides (HMO).
The Sialylated Human Milk Oligosaccharides (HMO) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sialylated Human Milk Oligosaccharides (HMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sialylated Human Milk Oligosaccharides (HMO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sialylated Human Milk Oligosaccharides (HMO) Market Report

Report Metric Details
Report Name Sialylated Human Milk Oligosaccharides (HMO) Market
Forecasted market size in 2030 US$ 1227.5 million
CAGR 14.5%
Forecasted years 2025 - 2030
Segment by Type
  • 3'-Sialyllactose
  • 6'-Sialyllactose
Segment by Application
  • Infant Formula
  • Food
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc., FrieslandCampina Ingredients
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sialylated Human Milk Oligosaccharides (HMO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sialylated Human Milk Oligosaccharides (HMO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Sialylated Human Milk Oligosaccharides (HMO) Market size in 2030?

Ans: The Sialylated Human Milk Oligosaccharides (HMO) Market size in 2030 will be US$ 1227.5 million.

Who are the main players in the Sialylated Human Milk Oligosaccharides (HMO) Market report?

Ans: The main players in the Sialylated Human Milk Oligosaccharides (HMO) Market are Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc., FrieslandCampina Ingredients

What are the Application segmentation covered in the Sialylated Human Milk Oligosaccharides (HMO) Market report?

Ans: The Applications covered in the Sialylated Human Milk Oligosaccharides (HMO) Market report are Infant Formula, Food, Others

What are the Type segmentation covered in the Sialylated Human Milk Oligosaccharides (HMO) Market report?

Ans: The Types covered in the Sialylated Human Milk Oligosaccharides (HMO) Market report are 3'-Sialyllactose, 6'-Sialyllactose

1 Sialylated Human Milk Oligosaccharides (HMO) Market Overview
1.1 Product Definition
1.2 Sialylated Human Milk Oligosaccharides (HMO) by Type
1.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2024 VS 2031)
1.2.2 3'-Sialyllactose
1.2.3 6'-Sialyllactose
1.3 Sialylated Human Milk Oligosaccharides (HMO) by Application
1.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Value by Application (2024 VS 2031)
1.3.2 Infant Formula
1.3.3 Food
1.3.4 Others
1.4 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts
1.4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue 2020-2031
1.4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales 2020-2031
1.4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sialylated Human Milk Oligosaccharides (HMO) Market Competition by Manufacturers
2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sialylated Human Milk Oligosaccharides (HMO), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Product Type & Application
2.7 Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
2.8 Global Sialylated Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.8.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sialylated Human Milk Oligosaccharides (HMO) Players Market Share by Revenue
2.8.3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sialylated Human Milk Oligosaccharides (HMO) Market Scenario by Region
3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2020-2031
3.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2020-2025
3.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region: 2026-2031
3.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2020-2031
3.3.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2020-2025
3.3.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2026-2031
3.4 North America Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.4.1 North America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2031)
3.4.3 North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.5.1 Europe Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2031)
3.5.3 Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Region
3.6.1 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2020-2031)
3.6.3 Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.7.1 Latin America Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2031)
3.7.3 Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2020-2031)
4.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2020-2025)
4.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Type (2026-2031)
4.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2020-2031)
4.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2020-2031)
4.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2020-2025)
4.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Type (2026-2031)
4.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2020-2031)
4.3 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2020-2031)
5.1.1 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2020-2025)
5.1.2 Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Application (2026-2031)
5.1.3 Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2020-2031)
5.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2020-2031)
5.2.1 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2020-2025)
5.2.2 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Application (2026-2031)
5.2.3 Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2020-2031)
5.3 Global Sialylated Human Milk Oligosaccharides (HMO) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
6.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information
6.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Description and Business Overview
6.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
6.2 DSM (Glycom A/S)
6.2.1 DSM (Glycom A/S) Company Information
6.2.2 DSM (Glycom A/S) Description and Business Overview
6.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.2.5 DSM (Glycom A/S) Recent Developments/Updates
6.3 Inbiose
6.3.1 Inbiose Company Information
6.3.2 Inbiose Description and Business Overview
6.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.3.5 Inbiose Recent Developments/Updates
6.4 Kyowa Hakko Bio
6.4.1 Kyowa Hakko Bio Company Information
6.4.2 Kyowa Hakko Bio Description and Business Overview
6.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.4.5 Kyowa Hakko Bio Recent Developments/Updates
6.5 GeneChem Inc.
6.5.1 GeneChem Inc. Company Information
6.5.2 GeneChem Inc. Description and Business Overview
6.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.5.5 GeneChem Inc. Recent Developments/Updates
6.6 FrieslandCampina Ingredients
6.6.1 FrieslandCampina Ingredients Company Information
6.6.2 FrieslandCampina Ingredients Description and Business Overview
6.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product Portfolio
6.6.5 FrieslandCampina Ingredients Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Chain Analysis
7.2 Sialylated Human Milk Oligosaccharides (HMO) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sialylated Human Milk Oligosaccharides (HMO) Production Mode & Process Analysis
7.4 Sialylated Human Milk Oligosaccharides (HMO) Sales and Marketing
7.4.1 Sialylated Human Milk Oligosaccharides (HMO) Sales Channels
7.4.2 Sialylated Human Milk Oligosaccharides (HMO) Distributors
7.5 Sialylated Human Milk Oligosaccharides (HMO) Customer Analysis
8 Sialylated Human Milk Oligosaccharides (HMO) Market Dynamics
8.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Trends
8.2 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
8.3 Sialylated Human Milk Oligosaccharides (HMO) Market Challenges
8.4 Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem
FrieslandCampina Ingredients
List of Tables
 Table 1. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sialylated Human Milk Oligosaccharides (HMO) Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sialylated Human Milk Oligosaccharides (HMO), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Product Type & Application
 Table 12. Global Key Manufacturers of Sialylated Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sialylated Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sialylated Human Milk Oligosaccharides (HMO) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2020-2025) & (Tons)
 Table 18. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2020-2025)
 Table 19. Global Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2026-2031) & (Tons)
 Table 20. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2026-2031)
 Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2020-2025)
 Table 23. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2026-2031)
 Table 25. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2025) & (Tons)
 Table 27. North America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2026-2031) & (Tons)
 Table 28. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Type (2020-2025)
 Table 51. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Type (2026-2031)
 Table 52. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2020-2025)
 Table 53. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2026-2031)
 Table 54. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2020-2025)
 Table 57. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2026-2031)
 Table 58. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Application (2020-2025)
 Table 61. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons) by Application (2026-2031)
 Table 62. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2020-2025)
 Table 63. Global Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2026-2031)
 Table 64. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2020-2025)
 Table 67. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2026-2031)
 Table 68. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Application (2026-2031)
 Table 70. Chr. Hansen (Jennewein Biotechnologie GmgH) Company Information
 Table 71. Chr. Hansen (Jennewein Biotechnologie GmgH) Description and Business Overview
 Table 72. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product
 Table 74. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
 Table 75. DSM (Glycom A/S) Company Information
 Table 76. DSM (Glycom A/S) Description and Business Overview
 Table 77. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product
 Table 79. DSM (Glycom A/S) Recent Developments/Updates
 Table 80. Inbiose Company Information
 Table 81. Inbiose Description and Business Overview
 Table 82. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product
 Table 84. Inbiose Recent Developments/Updates
 Table 85. Kyowa Hakko Bio Company Information
 Table 86. Kyowa Hakko Bio Description and Business Overview
 Table 87. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product
 Table 89. Kyowa Hakko Bio Recent Developments/Updates
 Table 90. GeneChem Inc. Company Information
 Table 91. GeneChem Inc. Description and Business Overview
 Table 92. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product
 Table 94. GeneChem Inc. Recent Developments/Updates
 Table 95. FrieslandCampina Ingredients Company Information
 Table 96. FrieslandCampina Ingredients Description and Business Overview
 Table 97. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product
 Table 99. FrieslandCampina Ingredients Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Sialylated Human Milk Oligosaccharides (HMO) Distributors List
 Table 103. Sialylated Human Milk Oligosaccharides (HMO) Customers List
 Table 104. Sialylated Human Milk Oligosaccharides (HMO) Market Trends
 Table 105. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
 Table 106. Sialylated Human Milk Oligosaccharides (HMO) Market Challenges
 Table 107. Sialylated Human Milk Oligosaccharides (HMO) Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sialylated Human Milk Oligosaccharides (HMO)
 Figure 2. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sialylated Human Milk Oligosaccharides (HMO) Market Share by Type: 2024 & 2031
 Figure 4. 3'-Sialyllactose Product Picture
 Figure 5. 6'-Sialyllactose Product Picture
 Figure 6. Global Sialylated Human Milk Oligosaccharides (HMO) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Sialylated Human Milk Oligosaccharides (HMO) Market Share by Application: 2024 & 2031
 Figure 8. Infant Formula
 Figure 9. Food
 Figure 10. Others
 Figure 11. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Sialylated Human Milk Oligosaccharides (HMO) Sales (2020-2031) & (Tons)
 Figure 14. Global Sialylated Human Milk Oligosaccharides (HMO) Average Price (US$/Kg) & (2020-2031)
 Figure 15. Sialylated Human Milk Oligosaccharides (HMO) Report Years Considered
 Figure 16. Sialylated Human Milk Oligosaccharides (HMO) Sales Share by Manufacturers in 2024
 Figure 17. Global Sialylated Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Sialylated Human Milk Oligosaccharides (HMO) Players: Market Share by Revenue in Sialylated Human Milk Oligosaccharides (HMO) in 2024
 Figure 19. Sialylated Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Sialylated Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2020-2031)
 Figure 22. North America Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2020-2031)
 Figure 23. United States Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2020-2031)
 Figure 34. China Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Sialylated Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Sialylated Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Type (2020-2031)
 Figure 53. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Sialylated Human Milk Oligosaccharides (HMO) by Application (2020-2031)
 Figure 56. Global Sialylated Human Milk Oligosaccharides (HMO) Price (US$/Kg) by Application (2020-2031)
 Figure 57. Sialylated Human Milk Oligosaccharides (HMO) Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Human Milk Oligosaccharides HMO Market Insights Forecast to 2030
Global Human Milk Oligosaccharides Market Research Report 2024
Global Human Milk Oligosaccharides in Infant Formula Market Research Report 2024
Global Biosynthetic Human Milk Oligosaccharides HMOs Market Research Report 2025
Global HMO Infant Formula Market Research Report 2025
Global 6 Sialyllactose 6 SL Market Research Report 2024
Global HMO Formula Milk Market Research Report 2024
Global HMO Children s Milk Powder Market Research Report 2024
Global HMO Milk Powder Market Research Report 2024
Global HMO Children s Formula Milk Powder Market Research Report 2024
Global Sialyllactose Market Research Report 2024
Global Mannose Oligosaccharide Market Research Report 2025
Global HMO Toddler Formula Milk Powder Market Research Report 2024
Global Oligogalactosyllactose Market Research Report 2025
Global Food Grade Galacto oligosaccharide Market Research Report 2025
Global Mannooligosaccharides Market Research Report 2025
Global Food Grade Isomaltooligosaccharides Market Research Report 2025
Global Oligosaccharides in Infant Nutrition Market Insights Forecast to 2030
Isomalto Oligosaccharide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligogalactose Market Research Report 2025

RELATED REPORTS

Global Frozen Bakery Semi-Finished Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11R16969
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Frozen Grain Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1O16663
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Coffee Solid Drinks Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28O16283
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Alcohol Drink Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N19935
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions